Pharm Meeting Minutes 2021.03.17

From IHE Wiki
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Meeting details

Location

Session 1 Login for Teams
Session 2 Login for Teams

Minutes

Q1 13:00- 14:30 Change proposals & Medication Lists

  • Participants:
    • Leonidas Tzimis
    • Stephane Spahni
    • Jose Costa Teixeira
    • Michael Tan
    • Jurgen Brandstatter
    • Jacqueline Surugue


Change Proposals

  • Switzerland has recently organized a projectathon. A third projectathon is planned. This includes CDA and FHIR profiles.

Overview: CP Overview

  • CP-PHARM-142 Proofreading / clarifications on CMPD, MTP, PADV profiles
    • Fixes something we have forgotten when we introduced COMMENT.
    • there are 2 definitions on XDS DocumentEntryType as a parameter.
  • CP-PHARM-143 Align definitions of doseQuantity & rateQuantity (PRE profile)
    • Dose and rate quantity is herited from PCC. Is it a quantity or a range. Which unit is allowed.There is a difference with PCC definition.
  • CP-PHARM-144 Forbid the use of ContextConductionInd (CMPD, MTP, PRE, DIS, PADV profiles)
    • Context conduction code. Relationships are inherited along to addtional attributes. There has been a lot of discussion within HL7. Proposed to discourage the use of context conduction
  • CP-PHARM-145 Cross-community PHARM-1 (CMPD profile)
    • A patient could live in another community. Need to forward the information to another community. Can reuse ITI38 and ITI18, but patient ID must be known.
  • CP-PHARM-146 New MHD-based transaction PHARM-5 (CMPD profile)
    • Need to support also RESTbased concepts which is then PHARM-5. Do we need to position it as a new approach to CMPD and not as temporarily solution? Is this a Swiss solution or an International approach? Jose is in a favor to keep low profile.
    • 3 possible solutions.
  • CP-PHARM-147 moodCode for patient-reported medications (MTP, PRE, DIS, PADV, CMA profiles)
    • In case a patient reports medication then it should be a event as mood code. In other cases it will be INT, whcih stands for intent.
  • OID Tree
    • Decide to leave the errors unchanged. Too much risk because of referenced chapters.

For information only:

  • CP-ITI-xxx "RegistryStoredQueryResponse_Message" versus "RegistryStoredQuery_Response_Message" spelling
  • CP-PCC-xxx Order of approachSiteCode, doseQuantity and rateQuantity varies --> may impact IHE PRE & MTP profiles

Medication lists

  • In Belgium there is understanding that there are different needs for a medication list.
  • We cannot force one formula for a medication list.
  • The patient records accumulates all the information from different resources.
  • Medication as a grouping item. It is more like a drill down mechanism.

14:30- 15:00 Break

Q2 15:00- 16:30 Vaccination Topics

Participants

  • Michael Tan
  • Jose Costa Teixeira
  • Jurgen Brandstaetter
  • Leonidas Tzimis
  • Jacqueline Surugue
  • Marc Robberecht
  • Stéphane Spahni

Work items

Logical Model

  • WHO model
  • European Model
  • Belgian Model
  • German Model
  • The IHE Pharmacy material can be found here:

https://github.com/IHE/pharm-vaccination

and

http://build.fhir.org/ig/IHE/pharm-vaccination/branches/master/StructureDefinition-ihe-pharm-vaccination.html

  • the WHO FHIR material can be found in Github.

https://github.com/who-int/svc

https://github.com/gcangioli/vaccineCertificate

http://fhir.ch/ig/ch-vacd/index.html


Issue to be discussed:

  • Site or route to be administered.
  • Protocol and where to store number of vaccinations.
  • How to register that a patient only needs one injection.
  • What value list do we use for status reason?
  • Action:
    • Jose to contact Giorgio for the WHO model
    • Michael Contact Line and Sylvia
    • Stephane to contact HL7 Roeland Luyckx

Pharmacy Technical Committee